Gregory W Barsness, MD - PowerPoint PPT Presentation

About This Presentation
Title:

Gregory W Barsness, MD

Description:

EECP: Pushing forward Gregory W Barsness, MD Director, EECP Program Mayo Clinic Rochester, MN EECP:Pushing forward Cuffs inflate sequentially to milk blood up to the ... – PowerPoint PPT presentation

Number of Views:88
Avg rating:3.0/5.0
Slides: 12
Provided by: AndrewM160
Category:

less

Transcript and Presenter's Notes

Title: Gregory W Barsness, MD


1
EECP Pushing forward
  • Gregory W Barsness, MD
  • Director, EECP Program
  • Mayo Clinic
  • Rochester, MN

2
EECPPushing forward
The process
  • Cuffs inflate sequentially to milk blood up to
    the heart in diastole.
  • (click to view animation)

3
EECPPushing forward
Indications/contraindications
  • INDICATIONS
  • Symptomatic ischemic coronary disease
  • CONTRAINDICATIONS
  • Aortic insufficiency
  • Severe valvular disease
  • Cardiac catheterization lt2 weeks
  • Arrhythmia
  • Severe hypertension (gt180/110mmhg)
  • History of DVT

4
EECPPushing forward
Pilot study
8 patients received 35 separate EECPsessions,
each lasting for 1 h, over 7 weeks
Pre-EECP Post-EECP
Mean PAMP (mW/cm4) 4.2 1.6 5.4 2.0
Mean EF 25 10 29 8
Mean heart rate (min-1) 73 5 65 5
preload-adjust maximal power preload-adjust maximal power preload-adjust maximal power
Dr John Gorcsan, 49th Annual Scientific Session
of the American College of Cardiology
5
EECPPushing forward
MUST-EECP
139 patients randomized to either active or
inactive EECP (double-blind)
Change post-treatment Exercise duration (s) Time to ST depression (s)
Inactive EECP 32 (p lt0.03) 4 (p lt0.74)
Active EECP 44 (p lt.001) 42 (p lt.002)
Between-group p value lt0.31 0.01

Arora RR, et.al. J Am Coll Cardiol 1999
331833-1840
6
EECPPushing forward
Whats next
  • Congestive Heart Failure study
  • Approved Sept 6, 2000 by the FDA
  • 180 patients in 18 centers across the US

7
EECPPushing forward
Mechanism
  • Exact mechanism unknown, but possibilities
    include
  • 1) collateral development provoked through
    increased expression of growth factors
  • 2) Passive exercise (blood pressure
    modification, sympathetic and neurohormonal
    changes)

8
EECPPushing forward
Hurdles to acceptance
  • Its a difficult therapy to watch. Its a lot of
    motion, its an aggressive diastolic milking of
    the blood centrally. On the table, patients are
    bouncing around and its a little uncomfortable
    for the patients to start. Its not painful at
    all, but its a little uncomfortable.
  • Gregory W Barsness, MD
  • Director, EECP Program
  • Mayo Clinic
  • Rochester, MN

9
EECPPushing forward
When to use ECP
  • Should be used in patients unable to be
    revascularized a second time and those in whom
    medical therapy has failed.
  • Avoid using in patients with active deep venous
    thrombosis.
  • Doesnt work well in people with claudication.
  • Approximately 10 of patients cannot tolerate
    EECP therapy, due to leg or back pain, or leg and
    skin abrasions caused by the leg cuffs.

10
EECPPushing forward
Long term follow up
  • International EECP Patient Registry
  • (University of Pittsburgh Graduate School of
    Public Health)
  • 2800 patients
  • 3300 cases
  • Intends to track 5000 patients with 3 year
    follow-up.

11
EECPPushing forward
Cost of treatment
  • Total cost for a course of 35 1-hour sessions
    ranges from 5000-6000.
  • HCFA approved coverage of External
    Counterpulsation treatment for severe angina on
    July 1, 1999.
  • Reimbursement was increased to 143.85 per
    session on Nov 8, 2000.
Write a Comment
User Comments (0)
About PowerShow.com